JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
* Cohen M et al. (2011) Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS One 6(1): e14540 * Xue A et al. (2012) Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer. 107(11):1883-91 * Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1